Related Experiment Video
Updated: Jul 16, 2026

Flow Cytometric Characterization of Murine B Cell Development
Published on: January 22, 2021
Heavy-chain-only antibody expression and B-cell development in the mouse
Marianne Brüggemann1, Jennifer A Smith, Michael J Osborn
1Laboratory of Developmental Immunology, The Babraham Institute, Babraham, Cambridge CB2 4AT, UK. marianne.bruggemann@bbsrc.ac.uk
Camelids possess unique heavy-chain-only antibodies, lacking light chains. This review explores their potential expression in mice and examines normal antibody development processes.
Area of Science:
- Immunology
- Molecular Biology
- Protein Engineering
Background:
- Mammalian antibodies typically comprise paired heavy (H) and light (L) chains.
- Single H-chains are usually retained in the endoplasmic reticulum, preventing their release.
- Heavy Chain Disease represents a pathological exception, involving mutated H-chains.
Purpose of the Study:
- To review the expression of H-chain-only antibodies in mice.
- To investigate if normal developmental processes for L-chain-independent antibody expression exist.
- To understand the structural and functional characteristics of camelid H-chain antibodies.
Main Methods:
- Review of existing literature on antibody structure and expression.
- Analysis of camelid antibody features, including the absence of the CH1 domain.
- Exploration of potential transgenic or engineered systems for H-chain antibody production in mice.
Main Results:
- Camelid antibodies are functional homodimers of H-chains, lacking L-chains and the CH1 domain.
- These H-chain-only antibodies retain antigen specificity and effector functions.
- The review discusses the feasibility and existing research on expressing such antibodies in murine models.
Conclusions:
- Camelid H-chain-only antibodies offer a unique structural and functional paradigm in immunology.
- Further research is needed to fully elucidate the mechanisms for their expression in mice.
- Understanding these mechanisms could pave the way for novel antibody-based therapeutics.
More Related Videos
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...